Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Capecitabine, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Capecitabine impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Capecitabine-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Capecitabine-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Capecitabine Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 2’-O-(5’-Deoxy-?-D-ribofuranosyl) Capecitabine-d11 | Stable Isotopes | CS-T-96600 | Not Available | Enquire |
| a-Capecitabine-d11 | Stable Isotopes | CS-T-96626 | Not Available | Enquire |
| Capecitabine-d11 | Stable Isotopes | CS-O-06460 | 1132662-08-8 | In Stock |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Capecitabine | API Standards | CS-O-01072 | 154361-50-9 | In Stock |
| Doxifluridine | API Standards | CS-O-07516 | 3094-09-5 | In Stock |
Metabolites
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| β-Capecitabine | Metabolites | CS-O-10489 | Not Available | Enquire |
| Tetrahydrouridine | Metabolites | CS-O-05908 | 18771-50-1 | In Stock |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine | Impurities | CS-T-52017 | 1262133-66-3 | In Stock |
| 3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine | Impurities | CS-T-52018 | 1262133-64-1 | In Stock |
| 3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine | Impurities | CS-T-52019 | 1262133-68-5 | In Stock |
| 5-Deoxy-5-Fluoro-N4-(methoxy carbonyl)Cytidine | Impurities | CS-O-57687 | Not Available | Enquire |
| 5-Fluoro-N-[(pentyloxy)carbonyl]cytidine | Impurities | CS-O-48859 | 396684-42-7 | Enquire |
| Capecitabine Impurity 5 | Impurities | CS-EO-00021 | Not Available | Enquire |
| Capecitabine-2',3'-cyclic Carbonate | Impurities | CS-T-50238 | 921769-65-5 | In Stock |
| Methyl 2,3-O-Isopropylidene-D-Ribofuranoside | Impurities | CS-EM-03216 | 72402-14-3 | In Stock |
EP Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Capecitabine (Y0001642) | EP Standards | CS-EG-00534 | 154361-50-9 | Enquire |
| Capecitabine impurity D (Y0001645) | EP Standards | CS-EG-00249 | 910129-15-6 | Enquire |
Intermediates
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | Intermediates | CS-T-51963 | 910129-15-6 | In Stock |